Myriad Genetics buy Wolfe Research
Start price
13.12.23
/
50%
€18.00
Target price
13.12.24
€25.92
Performance (%)
-23.89%
End price
14.12.24
€13.70
Summary
This prediction ended on 14.12.24 with a price of €13.70. The price of Myriad Genetics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.89%. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Myriad Genetics | 0.820% | 0.820% | -54.779% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Wolfe_Research for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $28.00 price target on the stock.
Ratings data for MYGN provided by MarketBeat
In the thread Trading Myriad Genetics
Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten